Lonza Group Ag Market Cap 2012-2023 | LZAGY

Lonza Group Ag market cap history and chart from 2012 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Lonza Group Ag market cap as of January 01, 2025 is $42.84B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $42.845B $7.478B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $195.647B 24.96
Stryker (SYK) United States $138.099B 31.12
Boston Scientific (BSX) United States $132.173B 38.00
EssilorLuxottica (ESLOY) France $111.000B 0.00
Medtronic (MDT) Ireland $102.083B 15.16
Haleon (HLN) United Kingdom $43.049B 27.97
GE HealthCare Technologies (GEHC) United States $35.910B 18.63
ResMed (RMD) United States $33.690B 27.68
Terumo (TRUMY) Japan $28.890B 40.80
Koninklijke Philips (PHG) Netherlands $23.818B 18.23
Zimmer Biomet Holdings (ZBH) United States $20.982B 13.36
Insulet (PODD) United States $18.473B 73.56
Baxter (BAX) United States $14.618B 9.51
Smith & Nephew SNATS (SNN) United Kingdom $10.746B 0.00
BellRing Brands (BRBR) United States $9.741B 39.19
Bio-Rad Laboratories (BIO) United States $9.136B 31.05
Demant (WILYY) Denmark $8.092B 0.00
Lantheus Holdings (LNTH) United States $6.197B 14.40
Haemonetics (HAE) United States $3.847B 18.77
Prestige Consumer Healthcare (PBH) United States $3.823B 19.01
ICU Medical (ICUI) United States $3.775B 35.94
Perrigo (PRGO) Ireland $3.450B 10.16
Envista Holdings (NVST) United States $3.289B 24.50
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.959B 19.05
GN Store Nord (GNNDY) Denmark $2.803B 17.97
Neogen (NEOG) United States $2.672B 30.83
LeMaitre Vascular (LMAT) United States $2.090B 50.79
Green Thumb Industries (GTBIF) United States $1.689B 29.56
AtriCure (ATRC) United States $1.475B 0.00
InMode (INMD) Israel $1.397B 8.40
Maravai LifeSciences Holdings (MRVI) United States $1.391B 0.00
AdaptHealth (AHCO) United States $1.259B 9.00
BioLife Solutions (BLFS) United States $1.219B 0.00
Owens & Minor (OMI) United States $0.976B 7.63
Curaleaf Holdings (CURLF) Canada $0.972B 0.00
CeriBell (CBLL) United States $0.926B 0.00
Phibro Animal Health (PAHC) United States $0.849B 14.98
Evolus (EOLS) United States $0.690B 0.00
Capricor Therapeutics (CAPR) United States $0.626B 0.00
VAREX IMAGING (VREX) United States $0.595B 26.22
Surmodics (SRDX) United States $0.566B 0.00
Omeros (OMER) United States $0.564B 0.00
Quanterix (QTRX) United States $0.420B 0.00
Verano Holdings (VRNOF) United States $0.420B 0.00
Cresco Labs (CRLBF) United States $0.405B 0.00
ZimVie (ZIMV) United States $0.384B 32.35
Valneva SE (VALN) France $0.351B 0.00
Biote (BTMD) United States $0.321B 7.04
Viemed Healthcare (VMD) United States $0.311B 29.63
Canopy Growth (CGC) Canada $0.299B 0.00
Sanara MedTech (SMTI) United States $0.290B 0.00
Cerus (CERS) United States $0.288B 0.00
OraSure Technologies (OSUR) United States $0.267B 17.90
Zynex (ZYXI) United States $0.253B 52.93
High Tide (HITI) Canada $0.246B 102.00
Aurora Cannabis (ACB) Canada $0.230B 0.00
Utah Medical Products (UTMD) United States $0.207B 14.26
MacroGenics (MGNX) United States $0.203B 0.00
Organigram Holdings (OGI) Canada $0.198B 0.00
Sanuwave Health (SNWV) United States $0.192B 2.70
TerrAscend (TSNDF) Canada $0.174B 0.00
Brainsway (BWAY) Israel $0.173B 92.20
FitLife Brands (FTLF) United States $0.153B 19.21
TriSalus Life Sciences (TLSI) United States $0.151B 0.00
Jin Medical (ZJYL) China $0.136B 0.00
Quipt Home Medical (QIPT) United States $0.121B 0.00
Fonar (FONR) United States $0.095B 10.70
Oramed Pharmaceuticals (ORMP) United States $0.094B 0.00
Veru (VERU) United States $0.093B 0.00
Exagen (XGN) United States $0.075B 0.00
InterCure (INCR) Israel $0.072B 0.00
Rockwell Medical (RMTI) United States $0.066B 34.17
Apyx Medical (APYX) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Cytosorbents (CTSO) United States $0.049B 0.00
Modular Medical (MODD) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.046B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Allurion Technologies (ALUR) United States $0.029B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.007B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.59
SNDL (SNDL) Canada $0.000B 0.00